Selective estrogen receptor modulators containing a phenylsulfonyl group

Details for Australian Patent Application No. 2003253129 (hide)

Owner Eli Lilly and Company

Inventors Hummel, Conrad Wilson; Lewis, Geroge Sal; Shepherd, Timothy Alan; Frank, Scott Alan; Dally, Robert Dean; Fong, Kin Chiu; Wallace, Owen Brendan; Dodge, Jeffrey Alan; Jones, Scott Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2003253129

PCT Number PCT/IB03/03349

PCT Pub. Number WO2004/009086

Priority 60/397,869 22.07.02 US; 60/450,233 25.02.03 US

Filing date 16 July 2003

Wipo publication date 9 February 2004

Acceptance publication date 11 December 2008

International Classifications

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/4535 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

C07D 295/092 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/13 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 333/54 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/56 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/64 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/72 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/397,869 22.07.02 US; 60/450,233 25.02.03 US

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003253129

11 December 2008 Application Accepted

  Published as AU-B-2003253129

9 April 2009 Standard Patent Sealed

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003253130-CONDENSED HETEROCYCLIC COMPOUNDS AS PDE-IV INHIBITORS FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS

2003253128-Modafinil polymorphic forms